CONFIDENTIAL

LFG Neuralink #2

Terms

  • Implied Valuation: ~$13.3B

  • Allocation: $500k

  • Structure: Secondary (company-approved tender)

    • Our co-investment partner has direct access to the primary fundraising round based on a strategic partnership.

    • Our SPV will invest into a vehicle managed by our co-investment partner.

  • Minimum Investment: $50k

  • Management Fee: (one-time, upfront)

  • Carry:

Timeline

  • Commitment: submit your desired amount by Tuesday, August 12th

  • Closing: funds will be due Wednesday, August 13th

Notes

  1. Terms: please note that while we believe these will be the final terms, they may change due to factors beyond our control as the company finalizes allocations with partners.

    • LFG+ Membership: here are our membership details

    • Management Fee: instead of charging an annual Management Fee, we handle it as a one-time, upfront (non-refundable) fee to simplify accounting and cap expenses. We apply the management toward administrative expenses, which are often charged separately by funds.

  2. Limited Allocation: due to high demand, we anticipate that this allocation will be heavily oversubscribed before the deadline. We will make efforts to honor desired commitment amounts, but cannot guarantee full allocations. LFG+ Members will get priority.

  3. Limited Information: given the sensitive nature of this deal, we will be limited in the information that we can share.

Click to Commit

About Neuralink

Neuralink, a pioneer in brain-computer interfaces (BCIs), is developing technology to connect human brains with computers, addressing neurodegenerative disorders and potentially enhancing cognitive capabilities. With the BCI market projected to grow from $2 billion in 2024 to $6 billion by 2030, driven by demand for treatments for paralysis and other neurological conditions, Neuralink is well-positioned to lead this emerging field. At its current valuation, Neuralink offers a compelling investment opportunity for those seeking exposure to a high-growth, transformative technology.

1. Founder: Elon Musk

Elon Musk’s track record as a serial entrepreneur underpins Neuralink’s potential. He has built some of the most transformative companies of our time: PayPal ($63B), Tesla ($888B, leading the EV market), SpaceX (~$350B, pioneering reusable rockets and space infrastructure), and xAI Holdings (valued at ~$113B, merging X’s real-time platform with cutting-edge AI models). Across each venture, Musk has consistently scaled disruptive technologies into category-defining giants. Neuralink benefits not just from his vision, but from the cross-company synergies — including AI advancements from xAI — positioning it to fundamentally reshape human-computer interaction.

2. Momentum: Human Trials Underway

Neuralink’s R1 surgical robot, which implants ultra-thin threads for precise brain interfacing, received FDA approval for human trials in May 2023. In January 2024, the first patient, with quadriplegia, used Neuralink’s BCI to control a computer cursor via thought alone. As of April 2025, three patients in the PRIME trial, targeting spinal cord injuries and ALS, have received implants, with plans for 20-30 more this year. These milestones mark steady progress toward scalable BCI applications.

3. Use Cases: Life-Changing

Neuralink’s current focus is enabling patients with paralysis or ALS to control devices through thought, as demonstrated in human trials and earlier monkey experiments (2020-2021), where subjects played games like Pong using BCIs. Elon Musk envisions broader applications, including treating depression, enhancing memory, or enabling cognitive enhancements like direct web access.

Press

  1. Neuralink targets $500 million raise at $8.5 billion valuation: report

  2. The man with a mind-reading chip in his brain - thanks to Elon Musk

  3. Yes, He Let Elon Musk Put a Chip in His Brain

  4. Neuralink Rival Gets FDA Clearance in Path to Less Invasive Brain Implants

  5. MIT Technology Review - What to Expect from Neuralink in 2025

Learn more at neuralink.com

Become an LFG+ Member

Get priority access and reduced fees.

Activate Now

©2025 LFG VENTURES

Please note that nothing herein constitutes or should be construed as financial or investment advice. While the information is believed to be accurate, it may include estimates, errors, or inaccuracies. You are responsible for conducting your own due diligence. You are solely responsible for determining whether any investment, investment strategy, security, or related transaction is appropriate for you based on your personal investment objectives, financial circumstances, and risk tolerance. Investors and users should consult with licensed legal professionals and investment advisors for any legal, tax, insurance, or investment advice. Investing in private is extremely speculative and involves a high degree of risk. You should not invest unless you are in a position to lose the entire amount of your investment. No public market currently exists for this opportunity, and there can be no assurance that such a public market will ever exist.